Vestal Point Capital, LP 13D and 13G filings for Alto Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:05 pm Sale | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Vestal Point Capital, LP | 2,064,075 6.500% | -420,925 (-16.94%) | Filing |
| 2026-02-17 4:05 pm Purchase | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Vestal Point Capital, LP | 2,485,000 8.000% | 2,485,000 (New Position) | Filing |